Diet Drug Belviq Withdrawn Due to Cancer Risk

Diet Drug Belviq Withdrawn Due to Cancer Risk

A clinical trial of the weight-loss drug Belviq (lorcaserin) shows an association with an increased risk of cancer, and the U.S. Food and Drug Administration is requesting that its maker withdraw the drug from the U.S. market. Eisai Inc. has already “submitted a request to voluntarily withdraw the drug,” Dr. Janet Woodcock, who directs the

Continue Reading...
1 Comments